(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine, 95.0%, 10g

4-BENZYL 1-TERT-BUTYL 2-(AMINOMETHYL)PIPERAZINE-1,4-DICARBOXYLATE, 95.0%, 250mg

1-(Furan-2-yl)propan-1-one, 98+%, 5g

6-Amino-4-methyl-1h-2,3-benzoxazin-1-one, 95%, 500mg

(3-((2-Chloro-4-methylphenyl)carbamoyl)-5-fluorophenyl)boronic acid, 98%, 50mg

(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)but-2-enamide (Dacomitinib Impurity), 98%, 50mg

1-Ethynylcyclohexene, 95.0%, 5g

1-cloroadamantano, mínimo 98 %, para síntesis, 100 g, envase de vidrio

Isopropylmethylsulfamoyl chloride, 95.0%, 2.5g

3,4-Dihydro-2H-1-benzopyran-8-amine, 98%, 1g

4-Chloro-5-methyl-5H-pyrrolo[3,2-d]pyrimidine, 95.0%, 10g

n-(2-Aminoethyl)morpholine-4-carboxamide oxalate, 97%, 500g

3-Fluoro-2-methoxypyridin-4-amine, 98%, 5g